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A prospective study of patients with pneumonia ndmitted to 
Groote Schuur Hosp i ta 1 t oo k place over a one year 
period in an attempt to assess the incidence of 
legionella pneumonia. Acute and convalescent serum 
samples we re · obtained from 1 1 3 patients. Eight 
patients (7,1%) showed a four fold rise in antibody 
titre against Legionella pneumophila group 1 antigen by 
indirect immunofluorescent test (IFAT). 
The findings suggest that legionella pneumonia, although not 
common, should be considered in the aetiology of 
pneumonia at Groote Schuur Hospital. 
The results are presented and a review of the literature is 
undertaken. 
HISTORY 
In July 1976, as part of the bicentennial celebrations, the 
Pennsylvania chapter of the American Legion held its 
annual convention in Philadelphia attended by 
approximately 4400 delegates. 
By the 2nd of August, 182 delegates had been taken ill with 
an acute respiratory illness characterized by fever, 
headache, myalgia and non-productive cough. Of these, 
147 required hospital admission and 29 died of severe 
pneumonia. (49,124) The epidemic curve suggested a 
common source outbreak and the hotel used as 
headquarters 
imp 1 i ca te d. 
for the convention was strongly 
Extensive investigations for the detection of toxins and 
infectious agents were undertaken. In January 1977, 
six months after the outbreak, the agent was identified 
by .Joseph McDade of the Centers for Disease Control 
(CDC) as a gram negative bacillus, found to represent a 
new family and subsequently named 
pneumophila. (17,89,125) 
By December 1978, cases of Legionnaires' disease had been 
reported from other states in America, from Europe, 
Israel and Australia. (23,64,91) 
5 
And so - a new killer organism was discovered - or was it? 
Subsequent evidence has shown that Legionella 
pneumophila is neither new, nor quite the killer it was 
thought to be. 
Retrospective serological studies suggest that the organism 
was responsible for an outbreak of an influenza-like 
illness designated "Pontiac Fever" which affected 14!~ 
people in a single building in Pontiac in 1968. (57) 
• 
6 
Serohistorical data suggest that an outbreak of pneumonia in 
a meat packing plant in 1957 was caused by Legione!_~ 
pneumophila. (103) 
Indeed, previously unidentified organisms isolated in 1947 
and 1959 have subsequently been identified as 
legionella species. (90) By 1988, cases of legionella 
infections, both sporadic and epidemic, had occurred 
worldwide including South Africa (131), although no 
outbreaks had been as severe as the original. 
To date 25 species of Legionella have been identified, of 
which 13 have been isolated from humans, suggesting a 
pathogenic role (Table 1). Almost all species have 
been recovered from environmental sites. Approxlma tely 
98% of infections are caused by Legion~~ pneumophila 
- particularly serogroup l. 
7 
THE ORGANISM 
Legionellaceae are aerobic, non-spore forming, gram 
negative, · non-encapsulated bacilli. The guanine and 
cytosine content of DNA is 39-43 %, which differentiates 
them from other gram negative organisms. 
Electron microscopy studies have shown the presence of 
Ultrastructural features flagella and pili. (25,115) 
are similar to those of other gram negative bacilli. 
( 2 4) 
The bacterial cell wall is characterized by large amounts 
(>80%) of branched chain fatty acids containing 
10 isoprene uni ts in their ~ iquino ~ with more than 
side chains - a relatively 
( 8 1 , 9 5 ) 
uncommon finding in nature. 
All species produce either catalase or peroxidase. (108) 
They are non-fermentative and produce neither urease 
nor nitrate reductase. Most strains are motile, 




largely on protein degradation, and 
degradation appears 
( 9 ) The organism has an 
relatively 
absolute 
requirement for 1-cysteine, ma y utilize other amino 
The 
acids, and growth is enhanced by the presence of ferric 
ions, ::><:'.'.ketoglutarate and charcoal. (55,82) The latter 
two substances may play a role in scavenging toxic 
oxygen radicals. (109) 
cell wall of Legionella species contains a 
lipopolysaccharide (LPS) with endotoxic function which 
differs in structure, function and biochemical 
characteristics from the LPS of enteric bacteria. 
(29,53) A major serogroup specific antigen carried on 
the side chains of the LPS may be responsible for the 
reactivity of sera in the IFAT. 
The major outer membrane protein (MOMP) of Legionella 
pneumophila has a molecular weight of approximately 
28kd and is immunogenic, although its role in immunity 
is not known. (53) 
A genus-wide 60kd membrane protein has been isolated and 
shown to react with sera prepared against 23 Legionella 
species, and may prove useful as an antigen for 
serological tests. (105,110) 
Immune response to the organism appears to be both cellular 
and humoral. 
8 
Some, but by no means all, isolates of Legionella contain 
plasmids (41,100), but their function has not been 
studied. 
Legionella pneumophila 1 ' the serogroup most commonly 
implicated in disease, has been subtyped by a number of 
methods including plasmid analysis, monoclonal antibody 
typing and enzyme analysis in an attempt to identify 
virulent strains. (92,123,130) Monoclonal antibody 
typing studies suggest that there is an association 
be tween the presence of an antigen 2 marker and 
virulence. (34,130) Further studies are necessary to 
assess the specificity and sensitivity of these 
methods. 
PATHOGENESIS 
There are two major aspects to the pathogenesis of an 
infectious disease:- organism virulence factors and 
host immune response - both cellular and humoral. 
Virulence factors: Legionella species produce a number of 
enzymes and toxins, including proteases, endotoxins and 
cytotoxins. (5,9,154) Proteases are thought to be 
important pathogenic factors in Legionella infections. 
This may be due to the low levels of antiprotease 
activity in the lung.(9) Animal studies have shown 
9 
that intranasal administration of proteases produces 
haemorrha g ic pneumonia with degradation of collagen 
fibres. (6) 
Legionella pneumo.!:~.!.~ is a fa cul ta ti v e intracellular 
pathogen whlch multiplies within a lveolar macrophages 
and monocytes, and can survive in human 
polymorphonuclear cells (PMNLs) after phagocytosis. 
( 2 4) 
Uptake of the organism occurs by bacteriopexis, a process 
whereby the organism binds 
surrounded by microvilli 








within ribosome-lined vacuoles, often leading to cell 
lysis. (101) 
Antibodies enhance the uptake of Legionella pneu~~phi~ by 
macrophages, but do not inhibit intracellular 
There is however, no evidence multiplication. (75) 
that the presence of antibodies enhances the 
pathogenicity of the organism. 
10 
Virulent pneumophila strains inhibit 
phagolysosomal fusion and acidification of phagosomes 
in monocytes. 
A cytotoxin of _!:egion~~ pneumophila inhibits oxygen 
As 
dependent killing following phagocytosis by PMNLs. (51) 
yet, however, no single virulence factor has been 
identified. Legionella pneumonia can be produced in 
guinea pigs by intratracheal or aerosol inoculation. 
The initial site of bacterial replication in these 
animals is in alveolar macrophages. (30) Interferon 
activated macrophages inhibit intracellular 
multiplication. (13) 
Host immunity: Mechanisms of immunity, and the relative 
roles of humoral and cellular immune defences are 
poorly understood. Most data suggest that phagocytosis 
by PMNLs and macrophages plays an important 
role.(30,75) 
Resident alveolar macrophages are an inadequate defence and 
do not inhibit multiplication of the organism. In 
animal models, PMNLs are recruited within 24 hours and 
are the first effective immune response. After three 
days a macrophage influx occurs. Most viable organisms 
11 
are found in macrophages, whil e those in PMNLs are 
usually non-viable. (30) 
The role of cell mediated immunity is not well defined. 
Lymphocyte blastogenic transformation occurs in 
lymphoid cells from sensitised, but not normal, guinea 
pigs. (162) It has been demonstrated that mononuclear 
cells from patients recovering from Legionella 
pneumophila infection respond to antigenic chall~nge by 
production of cytokines that activate monocytes, and by 
proliferation. Mononuclear cells from non-infected 
patients do not show this response. (163) 
This data shows that cell mediated immunity develops in 
patients and animals infected with Legionella species. 
It has been shown that passive transfer of antibodies may 
confer immunity. Antibody response to the organism is 
varied - antibodies may be of IgG, IgM and occasionally 
IgA classes, and may be specific for a single species 
or react with genus common antigens. (14) 
Antibodies may persist for months or even years, and it has 
b~en suggested that the switch from IgM to IgG does not 
always occur, possibly because new clones 
lymphocytes 
persisting 
may be stimulated to produce 







phenomenon does not occur with other intracellular 
organisms, so there may be another explanation. 
Direct or haematogenous spread of organisms may occur, 
although this is an unusual event, occurring primarily 
in immunocompromised patients. 
PATHOLOGY 
Pulmonary pathology and sequelae: Lobular, often bilateral, 
pneumonia is the predominant finding, although a lobar 
pattern is also common. There is no predilection for 
one specific lobe. Small multiple abscesses may occur. 
Cavitation, although uncommon, has been described, 
particularly in immunocompromised patients. (59) 
Serous or sero-sanguinous pleural effusions are not unusual, 
but are usually less than 200ml in volume. 
Microscopically there is usually an acute fibrinopurulent 
pneumonia with exudate of neutrophils, macrophages, red 







and the extent is 
of organisms present. 
Clusters of bacteria are found within macrophages and 
leucocytoclastic foci. (152) The interstitium may be 
1 3 
inflamed and widened with oedema, fibrin deposition a nd 
cellul a r infiltr a tion. 
El e ctron microscopy shows organisms in cytoplasmic vacuoles 
of cells. 
There may be organization and fibrosis. (15,26) Two 
patterns have been described:- one with interstitial 
fibrosis predominating, and a second in which there is 
also intra-alveolar organization and fibrosis. 
Disruption of alveolar epithelial lining and basement 
membrane has been demonstrated. ( 2 6) Bronchiolitis 
obliterans has been described in a compromised patient. 
( 121 ) 
Extrapulmonary: Lymph nodes are hyperplastic, or reactive 
with dilated macrophage filled sinuses. 
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Renal pathology includes acute pyelonephritis with organisms 
in tubules and abscesses, tubule-interstitial 
nephritis, rapidly progressive glomerulonephritis with 
crescent formation, acute tubular necrosis and 
mesangio-capillary I gA nephropa thy ( 1 , 3 2 , 4 7 , 6 1 , 1 4 4 ) • 
Organisms have not been demonstrated in the lesions in 
the latter four conditions. 
Focal myocarditis, with organisms in blood vessels, 
leukocytes and interstitium has been described. (146) 
Organisms have been demonstrated in lung, blood, liver, 
brain, pleural and pericardial fluids, prosthetic 
valves, kidney, lymph nodes, spleen, bone marrow and 
myocardium, but not in skeletal muscle or cerebro-
spinal fluid. 
CLINICAL 
Two major clinical syndromes are reco g nized: 
pneumonia and Pontiac fever. 
Legionella 
Legionella pneumonia has an incubation period of 2-10 days 
and manifest as malaise, myalgia, headache, arthralgia 
and fever, usually with abrupt onset. 
productive, although small amounts of 
Cough is non-
non-purulent 
sputum may be produced. Haemoptysis may occur in up to 
one third of cases. Dyspnoea and chest pain often 
pleuritic - are found in about two thirds of patients. 
Gastrointestinal symptoms such as watery diarrhoea, nausea 
and abdominal pain are common. 
Temperature rise often occurs in a step-wise pattern with 
tempera tu res reaching 39-400c in two thirds of 
1 5 
patients. There may be a relative bradycardia. 
Convalescence is often prolonged, and there may be long 
term sequelae. 
The disease cannot be distinguished from other pneumonias on 
clinical features alone, although multi system 
involvement, high fever with rigors and pneumonia with 
lack of purulent sputum are highly suggestive of the 
disease. 
Pontiac fever is an acute, short lived non-pneumonic illness 
with fever, headache, myalgia and cough lasting 2-7 
days followed by complete recovery. 
Asymptomatic seroconversion has been described. (62) 
Laboratory findings: Leucocytosis due to a neutrophilia is 
common, and ESR is usually raised. 
45-60% of patients have a hyponatremi11 (62,159) and about 
SO% have raised serum urea and creatinine. 
enzymes are elevated in 50-75 % of cases. (156) 
Complications of Legionella pneumonia: 
Liver 
Pulmonary complications include respiratory insufficiency, 
cavitation, and progression to pulmonary fibrosis. 
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Cardiovascular system: Myocarditis, pericarditis, and 
prosthetic valve endocarditis have been 
reported.(50,138,146) 
The most common neurological complication is a reversible 
encephalopathy manifested by confusion, disorientation 
and stupor. (79) Cerebellar dysfunction characterized 
by ataxia, gait disturbances, dysarthria and nystagmus 
have been described in 4% of 912 cases reviewed by 
Johnson et al. (79) 
Other manifestations include peripheral neuropathy, and very 
rarely, encephalomyelitis, focal signs and seizures. 
(11,66,69,79) CSF is usually normal, with the most 
common abnormality being a moderate pleocytosis-
The aetiology neutrophilic, monocytic or mixed. (79) 
of neurological derangements is unknown, and may be due 
to toxins or immunological factors. Legionella antigen 
has not been demonstrated in CSF and very rarely in 
brain tissue. (54) 
Renal failure, although well recognized, is uncommon. Acute 




glomerulonephritis have been implicated. (47 ,61,144) 
l 7 
Myalgia, arthralgia and weakness are common symptoms in 
Legionella infections. A number of cases of 
rhabdomyolysis with resultant myoglobinuria have been 
described. (20,63) As organisms have not been 
demonstrated in skeletal muscle, direct muscle damage 
by a toxin, or ischaemia due to vasoconstriction may be 
responsible. 
Miscellaneous complications: Skin rash (1) ' sinusitis 
( 1 2 2 ) , retinal abnormalities (so) ' Henoch-Schonlein 
purpura ( 2 2 ) , au to immune haemolytic anaemia (132), 
cutaneous abscess (2), haemodialysis fistula infections 
(80), wound infections (16), and appendix abscess (74) 
are very rare manifestations which have been described. 
In some cases the organism has not been demonstrated in 
lesions, and the association is tenuous. 
RADIOGRAPHIC FEATURES 
The radiographic patterns of Legionella pneumonia vary 
widely, with the most common being lobar or diffuse 
patchy infiltrates. (t,4) Small pleural effusions are 
common. There is no unique radiographic picture. The 





most frequent residual 
effusions or thickening 
18 
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(33%), small irregular shadows (24%), and atelectasis 
(19%). (44) 
DIAGNOSIS 
Diagnosis may be made in three ways:- Demonstration of a 
specific immune response, demonstration of antigen or 
nucleic acid in clinical specimens or culture of the 
organism. 
Serological Diagnosis: There are a number of limitations. 
Not all patients mount an antibody response. Diagnosis 
is retrospective as a fourfold rise in titre of 
specific antibodies must be demonstrated. Antibody 
production often occurs late, although seroconversion 
may occur within the first week in 27-40% of patients. 
(68,161) Finally, false positive results, although 
unusual, have been described in patients with gram-
negative, ricke ttsial and chlamydia! infections. 
(28,37,153) 
Tests should measure IgG and IgM. Antibodies to several 
serogroups or species may be produced in 
therefore serology cannot be used to 
an individual, 
identify the 
infecting strain. (45,106) The immunofluorescent test 
(!FAT) is the most widely used and best evaluated test, 
with a specificity of 99% and sensitivity of 80% using 
0 ther 
Legion e 11 a .E~~ um op hi 1 ! s er o group 1 antigen . ( 6 8 , 1 4 7 ) 
Different 
similar 
methods of antigen 
levels 
preparation produce 
results if for determination of 
positivity are adjusted. ( 10 4 , 11, 9 ) Re a ding and 
interpretation requires skilled personnel and results 
may be subjective. Methods to automate the test in 
order to overcome this problem have been described, but 
their efficacy has yet to be evaluated. (14,136) 
serological tests, including agglutination, 
counterimmuno-electrophoresis and enzyme linked 
immunosorbent assay (ELISA), have not been as well 
assessed, although the ELISA appears to be a useful 
alternative to the IFAT. (68,72,73,106,120) 
De tee tion of antigen or nucleic acid: The di rec t ---
fluorescent antigen test, (DFAT) the first method 
described, is still the most commonly used. The 
sensitivity is low - 25 to 50 %. Specificity is high, 
al though cross-reactions of antisera with other 
bacteria including Pseudomonas species and Borde tella 
pertussis have been reported. (7,102) These cross-
reactions are rare in clinical specimens, but have been 
described. (58,77) Use of monoclonal antibodies 






of Legionella infections 
reagents by environmental 




A nucleic acid probe has been produced. It is more 
sensitive than DFAT, and technically simple to use. A 
major drawback is the short half-life of the 
radioactive isotope in use at present. (107) 
Legionella antigen in urine has been detected by 
radioimmunoassay, enzyme-linked immunosorbent assay and 
latex agglutination. (8,84,133) Antigen may be 
detected early in the course of disease, but prolonged 
excretion occurs, so a positive test may reflect prior 
infection. (85) 
Culture: With the availability of commercial media, 
particularly buffered charcoal yeast extract agar with 





Sensitivity may be as high as 80%, 
on the type of specimen cul tu red. The 
are obtained from yields 
and bronchoscopy specimens, 
trans tracheal 
particularly 
bronchoalveolar lavage. ( 8 6) The organism can be 
readily cultured from sputum, especially with selective 
techniques such as acid or heat pretreatment; addition 
2 l 
of antibiotics to media; an antiserum-containing agar 
p 1 a te; and the use of discs impregnated with cysteine 
and ferric pyrophosphate on a deficient medium. 
(21,76,1126) 
Colonies may be visible after two days, and most cultures 
are positive within 5 days, with colonies having a 
characteristic ground glass appearance. 
Legionella pneumophila has been isolated from blood using a 
biphasic medium (12), and by the BACTEC radiometric 
system, although growth indices may not exceed the 
threshold limits. (113) Organisms, once isolated, may 
be identified by failure to grow on media lacking 
cysteine, DFAT, slide agglutination and the use of a 
DNA probe. (134,135,151) 
Direct inoculation onto dye-containing medium may aid in the 
identification of species by pigment production or 
fluorescence. (140) 
Legionella species are biochemically inert and traditional 
tests such as oxidase, ca ta 1 as e and gelatine 
liquefaction give variable results, and are not useful 
for identification. (153) 
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TREATMENT 
During the 1976 outbreak, the dru g found most effective was 
erythromycin. In vitro testin g and animal studies 
supported this clinical findin g . (97,98) 
the drug of choice for the 
Ery thromycin 
treatment of is still 
Legionella 
reported 
infections, although relapses have been 
usually following oral administration or 
inadequate doses. 
In vitro, naturally resistant strains of Legionella have not 
been reported. However resistance to erythromycin has 
been induced by passage of organisms 
containing media. (36) 
through drug-
Erythromycin is bactericidal in vitro, but bacteriosta tic in 
monocyt e cell cultur e s. (141) 
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In vitro sensiti v ity testing su gges ts th a t ~ ~ gion~~ 
pneumophila is sensitive to a number of antibiotics 
the aminoglycosides, chloramphenicol and including 
cefoxitin. 
medium. (38) 
The tetracyclines are inactivated by CYE 
Clinical efficacy of drugs does not correlate with in vitro 
sensitivity results, probably due to the inability of 
certain drugs to penetrate macrophages. Disc diffusion 
testing may be used to screen for antimicrobial 
resistance, but apparent sensitivity to certain drugs 
should be viewed with caution. (35) A cell model has 
been used to assess antibiotic activity 
Legionella species multi plying in macrophages. 
against 
This 
has led to the definl tion of a minimal extracellular 
concentration inhibiting the intracellullar 
multiplication (MIEC) of Legionella pneumophila. (141) 
There appears to be a good correlation between MIEC and 
clinical efficacy, and cell models allow the testing of 
drug combinations. 
Rifampicin is useful in combination with erythromycin for 
severe infections, but resistance may develop rapidly 
if it is used alone. The tetracyclines and co-
trimoxazole have been used to treat infections 
successfully, although their efficacy has not been 
f u 11 y e v a 1 u a te d • ( 11 8 , 1 5 8 ) The new quinolones such as 
pefloxacin(33), and the carbapenem, imipenern have been 
used successfully to treat patients. (46) 
Prophylaxis of high risk patients with erythromycin has been 
shown to pro tee t against infection in transplant 




There are three major factors in the epidemiology of 
Legionella infections:- an environmental source, 
transmission of the organism and a susceptible host. 
Three disease patterns have been described: 
1. Epidemics of Legionella pneumonia which have occurred 
2 • 
3 • 
worldwide. It has been suggested that the term 
"Legionnaires' Disease" be reserved for epidemic cases. 
The attack rate is low. 
Sporadic cases of Legionella pneumonia. fhe incidence 
varies greatly, although it is increasingly being 
recognized as an important cause of community and 
hospital acquired pneumonia. 
Pontiac fever. Due to the non-specific signs the 
incidence of sporadic cases is not known. The name 
"Pontiac fever" should be used only for outbreaks with 
a common source. The attack rate is about 95%. (31) 
Environmental sources: Legionella species grow in water, 
are ubiquitous in nature, have been isolated from 
rivers, mud, excavation s i te s , cooling towers and 
potable water (4,88) and very rarely cause disease. 
25 
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Their ability to survive so well in nature is in direct 
contrast to their fastidious nature in the laboratory, 
and it has been suggested that Legionella species have 
a symbiotic (or parasitic) relationship with algae and 
free-living amoebae (10,116,117), although Legionellae 
have been shown to survive and multiply in water free 
of these organisms. 
Outbreaks of disease have been associated with infected 
water in cooling towers and the organisms may be 
carried long distances from the source in 
aerosols.(83,111) Originally attention was focussed on 
air conditioners as the main source of infection, but 
it was later shown that potable water could be a 
source. 
associated 




cases and outbreaks 
and residential water 
supplies have been described. (93,129,142) Nosocomial 
outbreaks have also been ascribed to infected showers 
and to contamination of humidifiers. (65,155) 
Legionella species are isolated more readily from hot 
water systems (153), and the presence of certain types 
of rubbers may enhance their growth. (27,99) 
A number of methods have been used to identify the source of 
an outbreak by matching clinical and environmental 
isolates. These include plasmid profiles, restriction 
enzyme analysis, monoclonal antibody typing, outer 
membrane protein profiles and alloenzyme analysis. 
(19,41,100,130,137) 
The association between source and outbreak should be viewed 
with caution, as none of these methods are totally 
specific and there may also be more than one source of 
infection. 
Transmission: The widely accepted mode of transmission is 
by inhalation of aerosols. The differences in clinical 
features and attack rates between Legionella pneumonia 
and Pontiac fever are not explained by this theory, 
although the relative size of particles within aerosols 
may play a role in the pathogenesis of the two 
diseases. Muder et al (96) suggest that Pontiac fever 
may be acquired by inhalation and Legionella pneumonia 
by aspiration or direct instillation via respiratory 
devices. They point to the association with surgery 
and intubation as evidence. However these theories do 
not explain the occurrence of 





authors propose ingestion of organisms followed by 
bacteraemic spread as a mode of transmission, and cite 
the high incidence of gastrointestinal symptoms in 
patients with Legionella pneumonia. This seems an 
unlikely mode of transmission in a disease which 
primarily affects the respiratory tract. 
27 
There have been rare reports of pneumonic and non-pneumonic 
A 
forms of disease acquired 
suggesting organism load 
important in transmission. 
from 
or 
a common source ( 5 6) 
host factors may be 
carrier state in man has not been convincingly 
demonstrated, although it has been suggested. 
Indeed, the grow th of 





evidence of person to person transmission. 
may 
is 
( 18 ) 
be 
no 
Host factors: The majority of patients in the 1976 outbreak 
of Legionnaires' disease were healthy adults. Most 
cases of community acquired disease occur in 
immunocompetent hosts, although there are certain risk 
factors including -smoking, ethanol abuse, chronic 
pulmonary disease, diabetes, age over 50 years and male 
sex. However these could apply to most causes of 
bacterial pneumonia. Children are less susceptible, 
although cases have been described, particularly in 
children with malignancies. One series (3) showed 
seroconversion in 52% of 52 children under the age of 
four years with no evidence of Legionella pneumonia, 
suggesting subclinical infection or atypical illness. 
The high incidence of seroconversion may have been due 
to cross reactions with antibodies against other 
28 
organisms -vide the much lower seroprevalence in most 
adult studies. 
The majority of patients with nosocomial infections are 
immunocompromised, with renal and bone marrow 
transplant patients at particularly high risk. (87,94) 






who have undergone surgery 
to greater awareness of the 
Incidence: The true incidence of Legionella infections is 
not known. In retrospective studies, serological 
methods only are used and of ten no records of other 
causes of pneumonia in the group studied are available. 
Prospective studies . are difficult because a large 
number of diagnostic methods must be used, cases may be 
missed, and false emphasis may be placed on the 
isolation of potential pathogens such as llaemophilus 
influenzae or Streptococcus £~eumoniae. The incidence 
reported varies from <5% to 24 % of community acquired 
(52,157), and up to 25% of hospital acquired pneumonia. 
( 7 8) 
A prospective study of 142 cases of pneumonia by Yu et al 
(159) conducted over an 11 month period, showed that 
Legionella pneumophila was the most common single cause 
29 
of pneumonia (22,5 %). However, in 14 of the 32 cases 
diagnosis was made on a single antibody titre of 128, 
with no I~ fold rise demonstrated. The study did not 
differentiate between nosocomial and community acquired 
cases. 
In a study of 100 cases of pneumonia by Rudin and Wing 
(164), Legionella species were responsible for 7% of 
nosocomial infections, but no cases of community 
acquired legionellosis were detected. The authors did 
not indicate the to ta 1 number of pneumonia cases 
admitted during the period of the study. 
In a review of 92 patients with pneumonia in Denmark, 22 
cases (24%) of Legionella infection were diagnosed. 
The group of patients studied was unusual because the 
majority (47%) came from a community of elderly people, 
many of whom had underlying disease. {52) 
\ 
Control: The role of surveillance and decontamination 
measures in the prevention of nosocomial infections 
particularly, is controversial. (42,43,153) Some 
authors feel good housekeeping of water supplies is 
adequate, remembering Legionella species are resistant 
to temperatures up to 50°c, and to chlorine levels 
which eliminate enteric bacteria. Others suggest 
surveillance of high risk sites such as transplant and 
30 
intensive care units. A third approach is to carry out 
prospective surveillance of compromised patients with 
pneumonia to determine whether the hospital is a source 
of infection. One of the drawbacks of surveillance of 
water is that virulent strains cannot be differentiated 
from non-virulent strains, although monoclonal antibody 
typing may be 
subgroups. ( 3 4) 
useful 
Another 
in recognizing pathogenic 
problem is deciding when 
Legionella species are isolated from the environment in 
the absence of disease in patients, whether it is 
necessary to spend a great deal of time and money 
eliminating the organism from the environment. 
The most practical approach appears to be the monitoring of 
water outlets and respiratory equipment in intensive 
care units, combined with surveillance of pneumonia 
cases in these uni ts. Two methods of decontamination 
have been described. These are hyperchlorination using 
20-30 ppm of free chlorine, which may cause corrosion 
or "pasteurization" - flushing water of 70°c 
through the system several times. (L12) Decontamination 
is often unsuccessful because organisms in blind ends 





Legionella pneumonia was first described in 1976. Since 
then the disease has been reported worldwide, with 
widely varying incidence rates. The prevalence of 
Legionella pneumonia at Groote Schuur Hospital is 
unknown. Knowledge of this may aid the clinicians in 
the initial treatment of patients with pneumonia and 
allow the microbiologists to asse ss the necessity to 
provide diagnostic tests and decide which should be 
routinely available. 
The incidence of the disease is assessed and suggestions for 
further studies are made. 
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MATERIALS AND METHODS: 
Pneumonia cases: Patients over the age of 16 years with 
clinical and radiological signs of pneumonia attending 
Groote Schuur Hospital during a one year 
July 1987 to July 1988 were included in 
period from 
this study. 
Medical staff in the Emergency Unit were contacted 
daily, and those on medical wards once or twice weekly 
to ascertain the presence of pneumonia cases within 
these areas. Blood culture request forms were checked 
daily for possible cases. These procedures were 
carried out as regularly as the routine workload 
allowed. Patients were included in the study even if 
an aetiology had already been found. The de par tm en t of 
Radiology were asked to record the folder numbers of 
patients with chest radiographs suggestive of 
pneumonia, but it was felt that this would not be 
practical. 
Thos,e with underlying tuberculosis and acute exacerbations 
of chronic obstructive airways disease were excluded. 
Acute sera were collected on, or as soon as possible 
after the date 






weeks after the 
acute specimens by the investigator, or at the 
patient's nearest day hospital. All patients were 
given an envelope adressed to the sister in charge of 
the local day hospital. The envelope contained a 
labelled 10ml Vacutainer clotted blood tube, a note to 
the sister requesting that blood be taken from the 
patient, and an envelope addressed to the investigator 
for return of the blood sample. Patients were given a 
date on which to attend for a repeat specimen. 10-14 
days prior to the date of the follow-up visit, a letter 
of reminder was sent to all patients. Patients were 
told that attendance was voluntary. The same method of 
follow-up was used for everybody. Informed consent was 
obtained from all patients. 
Controls: Serum was obtained from 200 healthy blood donors 
to assess seroprevalence in the Cape Town population. 
Antigen preparation: A reference strain of Legionella 
pneumophila serogroup !-Philadelphia 1. (ATCC 33152) 
was grown for two days at 37°C on buffered CYE slopes. 
A suspension of the harvested organism was heat-killed 
at 100°c for 15 minutes. After titration against 
control sera of known titre, the antigen was used at a 
dilution of 1:20 in 0,5% buffered yolk sac. 
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Buffered yolk sac: Yolk sacs harvested from 12-14 day 
embryonated eggs were diluted in 0,02M phosphate 
buffered saline (PBS) to a concentration of 3% for 
serum dilution and 0,5% for antigen preparation. 
Preparation of slides: Glass microscope slides were coated 
with teflon to make 14 well fluorescent slides. A 1: 20 
suspension of heat-killed antigen was used to cover the 
wells. Slides were air-dried, fixed in acetone and 
stored at -20°c. 
two months. 
Frozen slides are stable for at least 
Indirect fluorescent antibody test (IFAT): All sera were 
screened at a dilution of 1:64, and any positive sera 
were then titred. Acute and convalescent sera were 
tested simultaneously. Fluorescent labelled rabbit 
antihuman globulin which detects IgG, IgM and IgA was 
used (Centers for Disease Control). 
Slides were read on a Zeiss mercury vapour epifluorescent 
microscope with FITC filter and scored on a scale from 
l+ (fluorescent organisms barely visible) to 4+ 
(brilliant yellow-green fluorescence). The serum titre 
was the reciprocal of the highest dilution giving at 
least l+ fluorescence. Results were only accepted if 
negative controls were negative and positive controls 
35 
were no more than one dilution above or below the 
stated value. 
Diagnosis of Legionella pneumonia: A fourfold rise in titre 
be tween acute and convalescent sera to a titre of at 
least 128. A single titre of 256 or greater was 
considered suggestive of infection at an undetermined 
time. 
RESULTS: 
Controls: Of 200 healthy blood donors (133 males, 67 
females) examined, 8(4%) had measurable antibody titres 
against Legionella 1 antigen (LPl). 
3(1,5%) had titres of 256 or greater suggestive of 
past infection. It was not possible to obtain 
histories from these donors, therefore recent infection 
could not be excluded, The majority of donors (70%) 
were between the ages of 20 and 39 years, and were not 
age matched to the pneumonia patients. Age distribution 
is shown in Table 2. 
Pneumonia patients: Of 173 patients initially included in 
the study, 60 were lost to follow up, therefore the 
y 
results reflect th·e remaining 1 1 3 (69 males, 44 
females). No factors contributing to non-compliance 
could be identified as all patients were treated in the 
36 
same way and lack of compliance did not appear related 
to socioeconomic factors. 
Age distribution is shown in Table 3. 
predominated. 
No single age group 
One hundred and eight cases were community-acquired, 3 
nosocomial (le presented )72 hours after admission) and 
in 2 cases it was difficult to assess whether the 
infection was acquired in the community or in hospital. 
Eighty seven had been ill for less than one week, 23 for 1-2 
weeks, and 3 for more than two weeks before acute sera 
were collected. 
Seventy one patients were treated in the emergency unit, and 
42 as in-patients. 
Eight patients showed a fourfold rise in titre of antibody 
to Legionella pneumophila 1, (Table 3) and were 
considered to have an acute Legionella irifection. Six 
of these patients responded to conventional therapy and 
two were treated with erythromycin following failure of 
response to conventional antibiotics. 
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The incidence among patients treated in the emergency unit 
was 5,6% (4/71), while among admitted cases it was 9,5% 
(4/42). There was no significant difference. (Fishers 
Exact Test). 
Two patients showed sustained antibody titres of 256 or 
greater with no rise in titre between acute and 
convalescent sera collected 4 weeks apart. (Table 3) 
In both cases acute sera were obtained less than one 
week after onset of symptoms, therefore it is unlikely 
that failure to demonstrate seroconversion was due to 
delay in obtaining acute sera. These 2 patients were 
not included as acute cases, as detectable antibody 
titres may persist for months or even years. (150) The 
Centers for Disease Control recommends that single or 
sustained high titreB in patients with sporadic illness 
be considered only presumptive evidence of infection at 
some time in the past. (1'50) 
DISCUSSION 
Controls: The seroprevalence among healthy donors was 4% if 
a titre of 64 was considered positive. However at this 
titre a number of positive results may be due to cross 
reactions. The seroprevalence was 2,5% using a titre 
of 128, and 1,5% at a titre of 256. Other studies have 
shown a prevalence varying from 1,7% to 19% using a 
39 
titre of 128 or greater. (4,12,70,127,128) Cape Town 
therefore is at the lower end of the reported range. 
Pneumonia patients: It is unlikely that all pneumonia cases 
admitted to GSH during the period of the study were 
included. However as many as possible were seen and 
hopefully these are a representative cross-section. 
Patients were not excluded if another infective 
aetiology was found; fir3tly because legionella may 
occur in association with other infections (52,157), 
and secondly because this would have resulted in a 
falsely high prevalence of legionella infections. 
Cases may have been missed, as only a serological method of 
diagnosis was used, and the disease may occur without 
seroconversion. 
The majority of patients in this study had community 
acquired disease. The incidence of legionella infection 
among the group tested was 7,1% (8/113), suggesting 
that the disease is not uncommon. Only a serological 
diagnosis was made, as most patients were already on 
antibiotics when seen by the investigator, and other 
methods of diagnosis of legionella infections are not 
routinely used in our laboratory. 
In many instances no routine bacteriological specimens were 
submitted and in other cases only one sputum specimen 
without accompanying blood cultures were submitted • No 
meaningful data as to the alternative causes for 
pneumonia could be obtained. It was therefore not 
possible to assess the relative frequency of legionella 
infections in this group of patients. It is only 
possible to state that the disease was not rare amongst 
pneumonia cases admitted 
Although numbers are too small 
the age distribution of 
to GSI! during that period. 
to assess the significance of 
legionella infections, the 
majority of cases occurred in the 40 to 49 age group. 
This contrasts with other studies in which the majority 
of cases occurred in those over 50 years of age. 
( 1 5 7 , 1 5 9 ) 
The ratio of male to female was 5 :3, and this probably 
reflects the proportion of males to females (69:44) in 
the study. 
All 8 cases of legionella infection presented in a 3 month 
period from March to June 1988. This may be a 
reflection of the high incidence of pneumonia cases 
occurring in this period. (Fig 1) The incidence of 
sporadic cases of legionella pneumonia tends to peak in 
late summer and autumn. 
ld 
Six of the eight patients responded to conventional therapy 
- supporting the observation that a large proportion of 
cases may recover without the appropriate therapy. (86) 
As there was insufficient time to examine all 173 patients 
in the initial study it was not possible to ascertain 
whether the patients had distinctive clinical or 
laboratory features. 
The results of this study suggest that the incidence of 
legionella infections is not high enough to warrant 
routine screening for this disease in all pneumonia 
A 
cases. However, there should be suspicion particularly 
in cases who do not respond to, or relapse on 
conventional therapy and erythromycln used early 
rather than late. 
further study of all nosocomial pneumonia cases, 
especially in compromised patients, would be of value 
to assess the incidence of legionella pneumonia and 
the necessity for surveillance of water determine 
supplies. Serological studies, cultures of sputum and 
blood, and more invasive specimens if warranted, should 
be undertaken. Anecdotally, there ls no evidence of a 
high incidence of nosocomial legionellosis at GSH, but 
no studies have been carried out to confirm this. A 
limited study of post-surgical cases is in progress. 
Liaison between clinician and microbiologist in suspected 
cases of legionellosis, either community or hospital 
acquired, would allow the laboratory to offer a more 
comprehensive diagnostic service including sputum and 




be put up on all bronchial brushings, 
from patients with non-responding 
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NUMBER OF PATIENTS 
AGE (YEARS) TITRES TOTAL 
<64 64 128 >=256 
(20 6 0 0 0 6 
20-29 79 1 1 0 81 
30-39 57 1 1 2 61 
40-49 37 0 0 0 37 
50-59 9 0 0 0 9 
>=60 4 1 0 1 6 
----------------------------------------------
TOTALS 192 3 2 3 200 
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TABLE 3 
AGE (YEARS) 4-FOLD RISE HIGH TITRE ( >=256) NEGATIVE TOTAL 
IN TITRE (NO RISE) 
NUMBERS OF PATIENTS 
<20 0 0 6 6 
20-29 1 0 25 26 
30-39 0 0 1 3 1 3 
40-49 5 0 19 24 
50-59 0 2 14 16 
60-69 1 0 20 21 
>=70 1 0 6 7 
-------------------------------------------------
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